Metagenomi Therapeutics Inc
MGX
NASDAQ
Biotechnology
$1.23
USD
0.00 (0.00%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $46.31M
Volume 83.5K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
TCRX | TScan Therapeutics Inc | $50.45M | - | +106.7% | - | |
TIL | Instil Bio Inc | $49.30M | - | - | - | |
MGX | Metagenomi Therapeutics Inc | $46.31M | - | -50.7% | - | |
KPTI | Karyopharm Therapeutics Inc | $45.10M | - | +6.3% | - | |
MCRB | Seres Therapeutics Inc | $44.93M | - | - | - | |
ALGS | Aligos Therapeutics Inc | $42.28M | - | +43.9% | - | |
TVGN | Tevogen Bio Holdings Inc | $42.16M | - | - | - | |
ELUT | Elutia Inc | $37.54M | 0.75 | -32.6% | - |
Top Peer by Growth
TScan Therapeutics Inc
+106.7% YoY Revenue
Lowest P/E Ratio
Elutia Inc
0.75x P/E
Best 1-Year Return
Aligos Therapeutics Inc
-11.5% Return